|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.9 TWD | -12.30% |
|
-27.03% | -59.88% |
| Apr. 18 | UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
UBI Pharma Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 633.82 million compared to TWD 644.29 million a year ago. Net income was TWD 47.21 million compared to TWD 22.36 million a year ago.
Basic earnings per share from continuing operations was TWD 0.4138 compared to TWD 0.2214 a year ago. Diluted earnings per share from continuing operations was TWD 0.4138 compared to TWD 0.2214 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -59.88% | 50.36M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
UBI PHARMA INC. 
